{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:18:20Z","timestamp":1788985100869,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","award":["unrestricted grant"],"award-info":[{"award-number":["unrestricted grant"]}],"id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13555-026-01844-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:23:40Z","timestamp":1783423420000},"page":"4403-4417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Itch, Scratching, and Sleep Mediate the Association between Disease Severity and Quality of Life in Pruritic Dermatoses: A Cross-Sectional Study"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0162-0742","authenticated-orcid":false,"given":"Manuel P.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-0772","authenticated-orcid":false,"given":"Pascale","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1563-7402","authenticated-orcid":false,"given":"Athanasios","family":"Tsianakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-3110","authenticated-orcid":false,"given":"Hermann","family":"Szymczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3805-8219","authenticated-orcid":false,"given":"Christian","family":"Apfelbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-7786","authenticated-orcid":false,"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9485-8627","authenticated-orcid":false,"given":"Claudia","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/jdv.18050","volume":"36","author":"MA Richard","year":"2022","unstructured":"Richard MA, Paul C, Nijsten T, et\u00a0al. Prevalence of most common skin diseases in Europe: a population-based study. J Eur Acad Dermatol Venereol. 2022;36:1088\u201396.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2340\/00015555-1159","volume":"91","author":"U Matterne","year":"2011","unstructured":"Matterne U, Apfelbacher CJ, Loerbroks A, et\u00a0al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol. 2011;91:674\u20139.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000319862","volume":"221","author":"S Stander","year":"2010","unstructured":"Stander S, Schafer I, Phan NQ, et\u00a0al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology. 2010;221:229\u201335.","journal-title":"Dermatology"},{"key":"1844_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2340\/00015555-3040","volume":"99","author":"C Schut","year":"2019","unstructured":"Schut C, Dalgard FJ, Halvorsen JA, et\u00a0al. Occurrence, chronicity and intensity of itch in a clinical consecutive sample of patients with skin diseases: a multi-centre study in 13 European countries. Acta Derm Venereol. 2019;99:146\u201351.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2340\/00015555-2263","volume":"96","author":"SE Marron","year":"2016","unstructured":"Marron SE, Tomas-Aragones L, Boira S, Campos-Rodenas R. Quality of life, emotional wellbeing and family repercussions in dermatological patients experiencing chronic itching: a pilot study. Acta Derm Venereol. 2016;96:331\u20135.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR6","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"RJ Hay","year":"2014","unstructured":"Hay RJ, Johns NE, Williams HC, et\u00a0al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527\u201334.","journal-title":"J Invest Dermatol"},{"key":"1844_CR7","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/jdv.20102","volume":"38","author":"S Stander","year":"2024","unstructured":"Stander S, Pereira MP, Zeidler C, et\u00a0al. EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: current challenges and future solutions. J Eur Acad Dermatol Venereol. 2024;38:1687\u201393.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR8","first-page":"681","volume":"120","author":"T Tonnies","year":"2023","unstructured":"Tonnies T, Schlesinger S, Lang A, Kuss O. Mediation analysis in medical research. Dtsch Arztebl Int. 2023;120:681\u20137.","journal-title":"Dtsch Arztebl Int"},{"key":"1844_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","volume":"405","author":"E Guttman-Yassky","year":"2025","unstructured":"Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Atopic dermatitis. Lancet. 2025;405:583\u201396.","journal-title":"Lancet"},{"key":"1844_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/bjd.21015","volume":"186","author":"G Yosipovitch","year":"2022","unstructured":"Yosipovitch G, Papp K, Forman S, et\u00a0al. The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trials. Br J Dermatol. 2022;186:1047\u20139.","journal-title":"Br J Dermatol"},{"key":"1844_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40257-023-00810-7","volume":"25","author":"G Yosipovitch","year":"2024","unstructured":"Yosipovitch G, Gooderham MJ, Stander S, et\u00a0al. Interpreting the relationship among itch, sleep, and work productivity in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE MONO-2. Am J Clin Dermatol. 2024;25:127\u201338.","journal-title":"Am J Clin Dermatol"},{"key":"1844_CR12","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/ced\/llae541","volume":"50","author":"G Yosipovitch","year":"2025","unstructured":"Yosipovitch G, de Bruin-Weller M, Wiseman M, et\u00a0al. Improved quality of life in patients treated with lebrikizumab monotherapy is mediated by improvements in itch and sleep: results from two phase III trials in patients with moderate-to-severe atopic dermatitis. Clin Exp Dermatol. 2025;50:1188\u201392.","journal-title":"Clin Exp Dermatol"},{"key":"1844_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2340\/00015555-3181","volume":"99","author":"EL Simpson","year":"2019","unstructured":"Simpson EL, Yosipovitch G, Bushmakin AG, et\u00a0al. Direct and indirect effects of crisaborole ointment on quality of life in patients with atopic dermatitis: a mediation analysis. Acta Derm Venereol. 2019;99:756\u201361.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/jdv.18850","volume":"37","author":"K Jaworecka","year":"2023","unstructured":"Jaworecka K, Kwiatkowska D, Marek-Jozefowicz L, et\u00a0al. Characteristics of pruritus in various clinical variants of psoriasis: final report of the binational, multicentre, cross-sectional study. J Eur Acad Dermatol Venereol. 2023;37:787\u201395.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/bjd.13065","volume":"171","author":"B Zhu","year":"2014","unstructured":"Zhu B, Edson-Heredia E, Guo J, Maeda-Chubachi T, Shen W, Kimball AB. Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial. Br J Dermatol. 2014;171:1215\u20139.","journal-title":"Br J Dermatol"},{"key":"1844_CR16","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.3390\/jcm10184081","volume":"10","author":"PC Taylor","year":"2021","unstructured":"Taylor PC, Bushmakin AG, Cappelleri JC, et\u00a0al. Itch as major mediator of effect of tofacitinib on health-related quality of life in psoriatic arthritis: a mediation analysis. J Clin Med. 2021;10:4081.","journal-title":"J Clin Med"},{"key":"1844_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/hdi.70003","volume":"30","author":"Y Ji","year":"2026","unstructured":"Ji Y, Park HJ, Kim S. Mediating effects of fatigue and sleep quality on uremic pruritus and quality of life among hemodialysis patients: a cross-sectional study. Hemodial Int. 2026;30:224\u201333.","journal-title":"Hemodial Int"},{"key":"1844_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/jdv.14570","volume":"32","author":"MP Pereira","year":"2018","unstructured":"Pereira MP, Steinke S, Zeidler C, et\u00a0al. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018;32:1059\u201365.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/ced.14722","volume":"46","author":"P Aggarwal","year":"2021","unstructured":"Aggarwal P, Choi J, Sutaria N, et\u00a0al. Clinical characteristics and disease burden in prurigo nodularis. Clin Exp Dermatol. 2021;46:1277\u201384.","journal-title":"Clin Exp Dermatol"},{"key":"1844_CR20","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1111\/jdv.16309","volume":"34","author":"MP Pereira","year":"2020","unstructured":"Pereira MP, Hoffmann V, Weisshaar E, et\u00a0al. Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study. J Eur Acad Dermatol Venereol. 2020;34:2373\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR21","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1111\/jdv.20038","volume":"38","author":"MP Pereira","year":"2024","unstructured":"Pereira MP, Gutsche A, Weisshaar E, et\u00a0al. Chronic nodular prurigo: association between comorbidities, itch and quality of life. J Eur Acad Dermatol Venereol. 2024;38:e984\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/jdv.15145","volume":"33","author":"E Brenaut","year":"2019","unstructured":"Brenaut E, Halvorsen JA, Dalgard FJ, et\u00a0al. The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries. J Eur Acad Dermatol Venereol. 2019;33:157\u201362.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR23","doi-asserted-by":"publisher","first-page":"2349\u201360 e3","DOI":"10.1016\/j.jaip.2025.05.033","volume":"13","author":"J Stolz","year":"2025","unstructured":"Stolz J, Salameh P, Asero R, et\u00a0al. Parameters linked with higher itch severity in chronic spontaneous urticaria-chronic urticaria registry results. J Allergy Clin Immunol Pract. 2025;13:2349-60 e3.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1844_CR24","doi-asserted-by":"publisher","first-page":"adv20329","DOI":"10.2340\/actadv.v104.20329","volume":"104","author":"JT Maul","year":"2024","unstructured":"Maul JT, Maul LV, Didaskalu JA, et\u00a0al. Correlation between dermatology life quality index and psoriasis area and severity index in patients with psoriasis: a cross-sectional global healthcare study on psoriasis. Acta Derm Venereol. 2024;104:adv20329.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR25","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/jdv.13689","volume":"30","author":"JG Holm","year":"2016","unstructured":"Holm JG, Agner T, Clausen ML, Thomsen SF. Quality of life and disease severity in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2016;30:1760\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR26","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/jdv.20148","volume":"38","author":"MP Pereira","year":"2024","unstructured":"Pereira MP, Zeidler C, Szymczak H, et\u00a0al. Acceptability and perceived benefits of validated pruritus assessment instruments in the dermatological office and clinic: the perspectives of patients and physicians. J Eur Acad Dermatol Venereol. 2024;38:1973\u201381.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1844_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","volume":"10","author":"JM Hanifin","year":"2001","unstructured":"Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Eval Group Exp Dermatol. 2001;10:11\u20138.","journal-title":"EASI Eval Group Exp Dermatol"},{"key":"1844_CR28","first-page":"238","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis\u2013oral therapy with a new retinoid. Dermatologica. 1978;157:238\u201344.","journal-title":"Dermatologica"},{"key":"1844_CR29","doi-asserted-by":"publisher","first-page":"adv00401","DOI":"10.2340\/00015555-3701","volume":"101","author":"C Zeidler","year":"2021","unstructured":"Zeidler C, Pereira MP, Augustin M, Spellman M, Stander S. Investigator\u2019s Global Assessment of Chronic Prurigo: a new instrument for use in clinical trials. Acta Derm Venereol. 2021;101:adv00401.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2340\/00015555-1246","volume":"92","author":"NQ Phan","year":"2012","unstructured":"Phan NQ, Blome C, Fritz F, et\u00a0al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol. 2012;92:502\u20137.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.70289","author":"C Zeidler","year":"2026","unstructured":"Zeidler C, Garcovich S, Bobko S, et\u00a0al. Quick assessment of quality-of-life in itch: an exploratory validation of the 5-item pruritus life quality. J Dtsch Dermatol Ges. 2026. https:\/\/doi.org\/10.1111\/ddg.70289.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1844_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2340\/00015555-0280","volume":"87","author":"T Patel","year":"2007","unstructured":"Patel T, Ishiuji Y, Yosipovitch G. Nocturnal itch: why do we itch at night? Acta Derm Venereol. 2007;87:295\u20138.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR33","doi-asserted-by":"publisher","first-page":"adv35427","DOI":"10.2340\/actadv.v104.35427","volume":"104","author":"X Sang","year":"2024","unstructured":"Sang X, Lu J, Tan L, et\u00a0al. The circadian rhythm of itching among 241 adults with atopic dermatitis: a cross-sectional study. Acta Derm Venereol. 2024;104:adv35427.","journal-title":"Acta Derm Venereol"},{"key":"1844_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ijwd.2021.02.010","volume":"7","author":"I Podder","year":"2021","unstructured":"Podder I, Mondal H, Kroumpouzos G. Nocturnal pruritus and sleep disturbance associated with dermatologic disorders in adult patients. Int J Womens Dermatol. 2021;7:403\u201310.","journal-title":"Int J Womens Dermatol"},{"key":"1844_CR35","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.4103\/jfmpc.jfmpc_2425_22","volume":"12","author":"P Shukla","year":"2023","unstructured":"Shukla P, Verma P, Tripathi S, Dwivedi AK, Shukla M, Suvirya S. Association of pruritus with sleep in patients with psoriasis and chronic spontaneous urticaria: a cross-sectional study. J Family Med Prim Care. 2023;12:1908\u201316.","journal-title":"J Family Med Prim Care"},{"key":"1844_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jaad.2020.08.059","volume":"84","author":"SP Patel","year":"2021","unstructured":"Patel SP, Khanna R, Choi J, et\u00a0al. Sleep disturbance in adults with chronic pruritic dermatoses is associated with increased C-reactive protein levels. J Am Acad Dermatol. 2021;84:265\u201372.","journal-title":"J Am Acad Dermatol"},{"key":"1844_CR37","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.jaad.2025.02.001","volume":"92","author":"C Mann","year":"2025","unstructured":"Mann C, Wollenberg A, Stander S, Staubach P, Thaci D, Zirpel H. Risk of developing sleep disorders and psychologic comorbidity in children with inflammatory skin diseases\u2014a population-based study. J Am Acad Dermatol. 2025;92:1261\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1844_CR38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamadermatol.2025.5449","volume":"162","author":"E Edwards","year":"2026","unstructured":"Edwards E, Jackson-Cowan L, Khalil N, Yap QV, Yosipovitch G. Sleep disturbance as a mediator between itch and quality of life. JAMA Dermatol. 2026;162:316\u20138.","journal-title":"JAMA Dermatol"},{"key":"1844_CR39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2018.08.005","volume":"142","author":"YS Chang","year":"2018","unstructured":"Chang YS, Chiang BL. Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol. 2018;142:1033\u201340.","journal-title":"J Allergy Clin Immunol"},{"key":"1844_CR40","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s13555-025-01449-4","volume":"15","author":"A Leung","year":"2025","unstructured":"Leung A, Haran K, Marquez-Grap G, et\u00a0al. The impact of psoriasis on sleep quality: examining the relationship between psoriasis, sleep, and mental health. Dermatol Ther (Heidelb). 2025;15:2247\u201354.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1844_CR41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/bjd\/ljaf213","volume":"193","author":"SG Kwatra","year":"2025","unstructured":"Kwatra SG, Pereira MP, Misery L, Mollanazar NK, Shah P, Wiggins S. Prurigo nodularis: disease burden, clinical features and approach to management. Br J Dermatol. 2025;193:642\u201352.","journal-title":"Br J Dermatol"},{"key":"1844_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljag121","author":"E Kocaturk","year":"2026","unstructured":"Kocaturk E, Grattan C, Cherrez I, et\u00a0al. The overall burden of chronic spontaneous urticaria\u2014the current landscape. Br J Dermatol. 2026. https:\/\/doi.org\/10.1093\/bjd\/ljag121.","journal-title":"Br J Dermatol"},{"key":"1844_CR43","volume":"17","author":"TA Moafa","year":"2025","unstructured":"Moafa TA, Mojiri ME, Alattas KK, et\u00a0al. The impact of sleep dysfunction on inflammatory skin diseases: a systematic review. Cureus. 2025;17:e99598.","journal-title":"Cureus"},{"key":"1844_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101695","volume":"66","author":"JR Chang","year":"2022","unstructured":"Chang JR, Fu SN, Li X, et\u00a0al. The differential effects of sleep deprivation on pain perception in individuals with or without chronic pain: a systematic review and meta-analysis. Sleep Med Rev. 2022;66:101695.","journal-title":"Sleep Med Rev"},{"key":"1844_CR45","doi-asserted-by":"publisher","first-page":"1260345","DOI":"10.3389\/fnmol.2023.1260345","volume":"16","author":"L Renkhold","year":"2023","unstructured":"Renkhold L, Wiegmann H, Pfleiderer B, et\u00a0al. Scratching increases epidermal neuronal branching and alters psychophysical testing responses in atopic dermatitis and brachioradial pruritus. Front Mol Neurosci. 2023;16:1260345.","journal-title":"Front Mol Neurosci"},{"key":"1844_CR46","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.it.2018.10.001","volume":"39","author":"MR Mack","year":"2018","unstructured":"Mack MR, Kim BS. The itch-scratch cycle: a neuroimmune perspective. Trends Immunol. 2018;39:980\u201391.","journal-title":"Trends Immunol"},{"key":"1844_CR47","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e33","volume":"24","author":"R Speeckaert","year":"2024","unstructured":"Speeckaert R, Belpaire A, Lambert J, Speeckaert M, van Geel N. Th pathways in immune-mediated skin disorders: a guide for strategic treatment decisions. Immune Netw. 2024;24:e33.","journal-title":"Immune Netw"},{"key":"1844_CR48","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41591-023-02320-9","volume":"29","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Mollanazar N, Stander S, et\u00a0al. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Nat Med. 2023;29:1180\u201390.","journal-title":"Nat Med"},{"key":"1844_CR49","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","volume":"389","author":"SG Kwatra","year":"2023","unstructured":"Kwatra SG, Yosipovitch G, Legat FJ, et\u00a0al. Phase 3 trial of nemolizumab in patients with prurigo nodularis. N Engl J Med. 2023;389:1579\u201389.","journal-title":"N Engl J Med"},{"key":"1844_CR50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jaci.2024.01.028","volume":"154","author":"M Maurer","year":"2024","unstructured":"Maurer M, Casale TB, Saini SS, et\u00a0al. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials. J Allergy Clin Immunol. 2024;154:184\u201394.","journal-title":"J Allergy Clin Immunol"},{"key":"1844_CR51","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1056\/NEJMoa2408792","volume":"392","author":"M Metz","year":"2025","unstructured":"Metz M, Gimenez-Arnau A, Hide M, et\u00a0al. Remibrutinib in chronic spontaneous urticaria. N Engl J Med. 2025;392:984\u201394.","journal-title":"N Engl J Med"},{"key":"1844_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","volume":"63","author":"A Mlynek","year":"2008","unstructured":"Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63:777\u201380.","journal-title":"Allergy"},{"key":"1844_CR53","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","volume":"133","author":"K Weller","year":"2014","unstructured":"Weller K, Groffik A, Church MK, et\u00a0al. Development and validation of the urticaria control test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133:1365\u201372.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01844-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:03:20Z","timestamp":1788984200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01844-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01844-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Manuel P. Pereira has received research funding from Almirall, Clinuvel, Leo Pharma, and Pfizer; is an investigator for Amgen, Allakos, ARS Pharmaceuticals, Celldex Therapeutics, Escient, Incyte, InflaRx, Mitsubishi, and Sanofi; has received consulting fees from Almirall, Amgen, Galderma, Incyte, Novartis, and Sanofi; and has received speaker honoraria and\/or travel fees from AbbVie, Amgen, Beiersdorf, Celltrion, CSL Behring, Doctorflix, Eli Lilly, Falk Foundation, FomF GmbH, GA2LEN, Galderma, Novartis, P.G. Unna Academy, Sanofi, StreamedUP, TouchMDT, and Zai Lab. Pascale Salameh declares no conflict of interest. Athanasios Tsianakas declares no conflict of interest. Hermann Szymczak declares no conflict of interest. Christian Apfelbacher has received institutional funding from Bionorica SE and consultancy fees from Bionorica SE, Dr Wolff Group, Incyte, LEO Pharma, Pfizer, WECARE, IVDK, and GFCNI. He is co-chair of the Harmonising Outcome Measures for Eczema (HOME) and Hand Eczema Core Outcome Set (HECOS) initiatives. Sonja St\u00e4nder is an Editorial Board member of\n                      Dermatology and Therapy\n                      . Sonja St\u00e4nder was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Sonja St\u00e4nder received grants from Almirall, Beiersdorf, Galderma, Sanofi Genzyme, and Trevi Therapeutics; consulting fees from AbbVie, Amgen, Bellus Health, Bristol-Meyers Squibb, Clexio, Galderma, Innocare Pharma, Klirna Biotech, Omnicuris Healthcare Private Ltd., Pfizer, P. G. Unna Academy, Sanofi, Vifor, and Zai Laboratory; honoraria from Beiersdorf, CRM GmbH, FomF GmbH, Galderma, L\u2019Or\u00e9al, Novartis, Pfizer, P. G. Unna Akademie, Sanofi, Streamed-Up!, TouchIME, UCB, Vifor, and WebMD; support for attending meetings from AbbVie, Attovia Therapeutics, Galderma, Lilly, Pfizer, Sanofi, Trevi Therapeutics, and Vifor; and participation on boards for AbbVie, Almirall, Amgen, Celldex, Focus-Insight Healthtech, Galderma, Gr\u00fcnenthal, Lilly, Regeneron, Sanofi, and Vifor. Claudia Zeidler has received consulting fees from Galderma and speaker honoraria\/travel fees from AbbVie, Almirall, Celldex, Dermasence, Leo, Novartis, Sanofi, and Unna Akademie.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}